Get Involved

Event Schedule

8:00 – 9:00

Registration + Coffee with Investors

9:00 – 9:15

Chair Welcome Address

9:15 – 9:45

Opening Keynote: The Next Decade of European Drug Discovery: From Modalities to Market Impact

New Target Spaces & Undruggables

9:45 - 10:10

Talk 1: Cracking the Dark Genome: New Biology for Complex Diseases

10:10 - 10:35

Talk 2: Unlocking Protein–Protein Interactions & Non-Coding RNAs

10:35 - 11:00

Talk 3: The Future of Targeted Protein Degradation

11:00 - 11:30

Coffee Break & Networking

AI & Digital Discovery Frontiers

11:30 - 11:55

Talk 4: Generative Chemistry Meets Real-World Data

11:55 - 12:20

Talk 5: LLMs in Drug Discovery: Beyond Hype into Practice

12:20 - 12:45

Talk 6: Autonomous Labs: AI-Driven Design, Test & Learn Loops

12:45 - 13:45

Networking Lunch & Roundtables

Novel Modalities in Chemistry & Beyond

13:45 - 14:10

Talk 7: Chemical Space Expansion: Macrocycles, Covalent Inhibitors, and Hybrid Molecules

14:10 – 14:35

Talk 8: Small Molecules vs. Modalities: Where’s the Value?

14:35 – 15:00

Case Study: Designing Drugs with Structural Plasticity

15:00 - 15:30

Coffee Break & Partner Meetings

15:30 – 16:00

Panel Discussion: Where Will the Next Breakthrough Modalities Come From?

16:00

Networking Drinks Reception

8:30 – 9:00

Morning Coffee

9:00 – 9:20

Keynote: Translational Models Driving Precision Drug Discovery

Translational Medicine & Next-Gen Models

9:20 – 9:45

Talk 9: Organoids, Microphysiological Systems & Organs-on-Chip

9:45 - 10:10

Talk 10: Spatial Omics as a Discovery Accelerator

10:10 - 10:35

Talk 11: Biomarker Discovery & Validation in Early Drug Development

10:35 - 11:05

Coffee Break

Biologics, Cell & Gene Therapies

11:05 - 11:30

Talk 12: Antibody-Drug Conjugates & New Biologic Modalities

11:30 - 11:55

Talk 13: Next-Gen Oligonucleotide Therapeutics

11:55 - 12:20

Talk 14: Cell & Gene Therapies in Discovery: The Road Ahead

12:20 - 13:20

Lunch Break & Roundtables

Biotech Market Trends & Investments

13:20 - 13:45

Talk 15: Platform Biotechs vs. Single-Asset Plays: Shaping Europe’s Market

13:45 - 14:10

Talk 16: Navigating VC and Non-Dilutive Funding in 2026

14:10 - 14:50

Investor Panel: Where Pharma & Biotech Partnerships Will Flourish

14:50 - 15:20

Coffee Break

Future Outlook & Closing

15:20 - 15:55

Panel: What Will Discovery Look Like in 2030? (AI, Modality Mix, Biotech Landscape)

15:55 - 16:30

DDIP Awards Ceremony

Breakthrough Discovery Platform
AI/ML Innovation in Discovery
Rising Star Scientist
Best Academia–Industry Collaboration
People’s Choice Award
16:30

Closing Remarks & Networking